R&D Systems Recombinant Human ErbB2/Her2 Fc Chimera Protein CF
R&D Systems Recombinant Human ErbB2/Her2 Fc Chimera Protein CF blocks anti-ErbB2 mediated inhibition of the SK‑BR‑3 human breast cancer cell line.
Manufacturer: R&D Systems 1129ER01M
DescriptionMeasured by its ability to block anti-ErbB2 mediated inhibition of SK-BR-3 human breast cancer cell proliferation. Brodowicz, T. et al. (1997) Int. J. Cancer 73:875. The ED 50 for this effect is 20-80 ng/mL in the presence of 0.6 µg/mL Goat Anti-Human ErbB2/Her2 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1129 ).
|>90%, by SDS-PAGE with silver staining|
|<0.10EU per 1μg of the protein by the LAL method.|
|Lyophilized from a 0.2μm filtered solution in PBS.|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
|Reconstitute at 100μg/mL in sterile PBS.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok